BCI Pharma is a biotechnology company dedicated to the discovery and development of innovative solutions in key areas of women's health. Specialising in the discovery of selective and innovative kinase inhibitors, BCI Pharma's ambition is to address the unmet medical needs for pathologies and syndromes encountered specifically in women, such as endometriosis, polycystic ovary syndrome, infertility and female cancers.